An advisory committee to the Food and Drug Administration (FDA) was told that unreasonable FDA restrictions on healthcare use of safe and effective antibacterial ingredients could jeopardize the safety of patients and healthcare workers alike. In a presentation to FDA’s Nonprescription Drugs Advisory Committee (NDAC) organized by the American Cleaning Institute (ACI), health professionals and industry safety experts said that active ingredients used in antibacterial hygiene products “clearly save lives” and are recognized as the “standard of care” for reducing healthcare infections.
“A robust body of research supports the safety of active ingredients used in healthcare antiseptic products,” wrote ACI in comments submitted to the NDAC panel. “Any suggestion that the benefit or risk of these products is in question, especially by FDA, could lead to unintended adverse consequences if usage patterns were to change in the healthcare setting.”
FDA is slated to propose a new set of rules governing antibacterial healthcare hygiene products in 2015.
Previous public announcements made by FDA – questioning the safety and efficacy of key antibacterial ingredients – have failed to acknowledge the full database of studies and research supporting the ingredients’ benefits and safety profiles.
“Healthcare providers need to have a full range of antibacterial actives at their disposal to best meet their infection control needs,” says Dr. Paul DeLeo, ACI associate vice president of environmental safety. “Any effort by FDA that would impede availability of these important ingredients would put patients and healthcare personnel at risk.”
Speakers at the ACI-organized presentation urged the Advisory Committee to recommend that FDA conduct a full risk assessment of currently available health and safety data on antibacterial ingredients.
“The active ingredients used in healthcare antiseptic drug products have a very favorable benefit/risk ratio demonstrated over many years of extensive use,” says Dr DeLeo. “These products clearly save lives by reducing bacterial transmission, which can cause infections in healthcare settings. By reducing healthcare-associated infections, these products also reduce healthcare costs.”
Source: American Cleaning Institute (ACI)
Tackling Health Care-Associated Infections: SHEA’s Bold 10-Year Research Plan to Save Lives
December 12th 2024Discover SHEA's visionary 10-year plan to reduce HAIs by advancing infection prevention strategies, understanding transmission, and improving diagnostic practices for better patient outcomes.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
The Importance of Hand Hygiene in Clostridioides difficile Reduction
November 18th 2024Clostridioides difficile infections burden US healthcare. Electronic Hand Hygiene Monitoring (EHHMS) systems remind for soap and water. This study evaluates EHHMS effectiveness by comparing C difficile cases in 10 hospitals with CMS data, linking EHHMS use to reduced cases.